Swipe om te navigeren naar een ander artikel
To assess EQ-5D-5L (5L) validity in patients with acute stroke, in comparison with EQ-5D-3L (3L).
Cross-sectional study of 408 patients during index hospitalization. We compared 5L and 3L in terms of feasibility, frequency of unique health states, ceiling effect and discriminatory power (informativity). We assessed construct validity in terms of known-groups validity and convergent validity of 5L dimensions with other stroke outcome measures.
The overall proportion of patients with acute stroke reporting ‘no problems’ with 3L—6.1 % was further reduced to 5.6 % with 5L (relative reduction of 8.2 %). The highest improvement in relative discriminatory power, when moving from 3L to 5L, was noticed in pain/discomfort and anxiety/depression dimensions (Shannon Evenness Index 0.91 for both 5L dimensions; relative increase 34.4 and 29.1 %, respectively). Known-groups validity tests confirmed prior hypotheses: Health state utilities were lower in following subpopulations—females, patients with high modified Rankin Scale (mRS) score, low Barthel Index (BI) or VAS score, patients with subarachnoid hemorrhage or intracerebral hemorrhage, and when proxy respondent was used. Convergence of EQ-5D-5L dimensions with mRS, BI and EQ VAS was improved or at least the same as for 3L dimensions.
Results support the validity of the EQ-5D-5L descriptive system as a generic health outcome measure in patients with acute stroke, demonstrating some psychometric advantages in comparison with EQ-5D-3L.
Janssen, M. F., Pickard, A. S., Golicki, D., Gudex, C., Niewada, M., Scalone, L., et al. (2013). Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: A multi-country study. Quality of Life Research, 22(7), 1717–1727. doi: 10.1007/s11136-012-0322-4. CrossRefPubMedCentralPubMed
Scalone, L., Ciampichini, R., Fagiuoli, S., Gardini, I., Fusco, F., Gaeta, L., et al. (2013). Comparing the performance of the standard EQ-5D 3L with the new version EQ-5D 5L in patients with chronic hepatic diseases. Quality of Life Research, 22(7), 1707–1716. doi: 10.1007/s11136-012-0318-0. CrossRefPubMed
Lee, C. F., Luo, N., Ng, R., Wong, N. S., Yap, Y. S., Lo, S. K., et al. (2013). Comparison of the measurement properties between a short and generic instrument, the 5-level EuroQoL Group’s 5-dimension (EQ-5D-5L) questionnaire, and a longer and disease-specific instrument, the Functional Assessment of Cancer Therapy-Breast (FACT-B), in Asian breast cancer patients. Quality of Life Research, 22(7), 1745–1751. doi: 10.1007/s11136-012-0291-7. CrossRefPubMed
Golicki, D., Niewada, M., van Hout, B., Janssen, M. F., & Pickard, A. S. (2014). Interim EQ-5D-5L value set for Poland: First crosswalk value set in Central and Eastern Europe. Value in Health Regional Issues, 4C, 19–23. CrossRef
Shannon, C. E. (1948). A mathematical theory of communication. The Bell System Technical Journal, 27, 379–423. CrossRef
Fayers, P. M., & Machin, D. (2007). Scores and measurements: validity, reliability, sensitivity. Quality of life: The assessment, analysis and interpretation of patient-reported outcomes (pp. 77–108). Chichester: Wiley. CrossRef
Niewada, M., Kobayashi, A., Sandercock, P. A., Kaminski, B., & Czlonkowska, A. (2005). Influence of gender on baseline features and clinical outcomes among 17,370 patients with confirmed ischaemic stroke in the international stroke trial. Neuroepidemiology, 24(3), 123–128. doi: 10.1159/000082999. CrossRefPubMed
Juniper, E. F., Guyatt, G. H., & Jaeschke, R. (1996). Chapter 6: How to develop and validate a new health-related quality of life instrument. In B. Spilker (Ed.), Quality of life and pharmacoeconomics in clinical trials (2nd ed., pp. 49–56). Philadelphia: Lippincott-Raven Publishers.
Pickard, A. S., Johnson, J. A., Feeny, D. H., Shuaib, A., Carriere, K. C., & Nasser, A. M. (2004). Agreement between patient and proxy assessments of health-related quality of life after stroke using the EQ-5D and Health Utilities Index. Stroke, 35(2), 607–612. doi: 10.1161/01.str.0000110984.91157.bd. CrossRefPubMed
- Validity of EQ-5D-5L in stroke
M. F. Janssen
A. Simon Pickard
- Springer International Publishing